(BRK.A), (BRK.B)
Berkshire Hathaway’s Lubrizol, a global leader in specialty chemistry, has launched its Beauty Research Institute in Shanghai, China. This new site is set to become a strategic hub for advancing in vivo beauty testing, leveraging decision science to develop next-generation beauty ingredients. It aims to foster innovation, enhance collaboration, and accelerate time-to-market for Lubrizol’s beauty and personal care customers in the region and worldwide.
The institute expands Lubrizol’s R&D and lab network in the Asia Pacific, featuring advanced clinical testing equipment and collaborative spaces modeled after the company’s renowned testing facilities in Barcelona. It offers state-of-the-art services, including claim substantiation, sensory evaluation, and consumer insight generation, along with training and education programs. By integrating artificial intelligence and computer vision, the center is poised to provide customized support to customers, driving faster and more efficient innovation.
Bernardo Medeiros, Vice President of Lubrizol Beauty, highlighted the significance of the Shanghai institute, noting China’s pivotal role as the fastest-growing beauty market. He emphasized that combining global technologies with local insights will enable Lubrizol to deliver solutions that resonate both locally and globally.
With nearly a century of innovation history, Lubrizol has a strong presence in Asia Pacific, including commercial offices, manufacturing sites, and technical centers. Henry Liu, Vice President of Lubrizol APAC, underscored China’s influence in technological advancement and stated that the new institute reinforces Lubrizol’s commitment to local innovation and talent development.
Lubrizol’s Beauty business offers a wide range of ingredients and expertise for various beauty products, continually winning industry awards for its contributions to active and functional beauty ingredients.
© 2024 David Mazor
Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell a stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.